Caxton Associates LP Increases Stock Holdings in Nu Skin Enterprises, Inc. (NYSE:NUS)

Caxton Associates LP boosted its position in shares of Nu Skin Enterprises, Inc. (NYSE:NUS) by 155.4% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 48,842 shares of the company’s stock after acquiring an additional 29,718 shares during the period. Caxton Associates LP’s holdings in Nu Skin Enterprises were worth $515,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also bought and sold shares of NUS. Signaturefd LLC grew its position in shares of Nu Skin Enterprises by 72.6% during the 2nd quarter. Signaturefd LLC now owns 3,797 shares of the company’s stock valued at $40,000 after purchasing an additional 1,597 shares in the last quarter. CWM LLC grew its position in Nu Skin Enterprises by 38.4% during the first quarter. CWM LLC now owns 3,286 shares of the company’s stock worth $45,000 after buying an additional 911 shares in the last quarter. Canada Pension Plan Investment Board bought a new position in Nu Skin Enterprises in the 2nd quarter worth about $47,000. Public Employees Retirement System of Ohio raised its holdings in shares of Nu Skin Enterprises by 30.5% in the 1st quarter. Public Employees Retirement System of Ohio now owns 3,926 shares of the company’s stock valued at $54,000 after acquiring an additional 918 shares in the last quarter. Finally, Covestor Ltd boosted its position in shares of Nu Skin Enterprises by 90.1% during the 1st quarter. Covestor Ltd now owns 4,353 shares of the company’s stock valued at $60,000 after acquiring an additional 2,063 shares during the last quarter. Institutional investors own 82.84% of the company’s stock.

Nu Skin Enterprises Stock Up 3.2 %

Shares of NYSE NUS opened at $7.07 on Friday. The stock has a market capitalization of $351.15 million, a P/E ratio of -117.83 and a beta of 1.13. The company has a debt-to-equity ratio of 0.62, a current ratio of 2.12 and a quick ratio of 1.33. Nu Skin Enterprises, Inc. has a one year low of $6.72 and a one year high of $21.99. The firm’s 50 day simple moving average is $9.10 and its two-hundred day simple moving average is $11.27.

Nu Skin Enterprises (NYSE:NUS) last issued its earnings results on Thursday, August 8th. The company reported $0.21 EPS for the quarter, topping analysts’ consensus estimates of $0.17 by $0.04. Nu Skin Enterprises had a negative net margin of 8.05% and a positive return on equity of 7.80%. The company had revenue of $439.10 million for the quarter, compared to analysts’ expectations of $431.87 million. During the same quarter last year, the company earned $0.54 EPS. The firm’s revenue was down 12.2% compared to the same quarter last year. As a group, analysts expect that Nu Skin Enterprises, Inc. will post 0.78 EPS for the current fiscal year.

Nu Skin Enterprises Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Wednesday, September 11th. Investors of record on Friday, August 30th were issued a dividend of $0.06 per share. This represents a $0.24 annualized dividend and a yield of 3.39%. The ex-dividend date of this dividend was Friday, August 30th. Nu Skin Enterprises’s dividend payout ratio is presently -400.00%.

Wall Street Analysts Forecast Growth

Several research analysts recently weighed in on NUS shares. StockNews.com upgraded shares of Nu Skin Enterprises from a “hold” rating to a “buy” rating in a research report on Friday, September 6th. DA Davidson lowered their price objective on shares of Nu Skin Enterprises from $12.50 to $11.00 and set a “neutral” rating on the stock in a research report on Monday, August 12th. Finally, Citigroup cut their target price on shares of Nu Skin Enterprises from $14.00 to $11.50 and set a “neutral” rating for the company in a research report on Friday, August 9th. Three research analysts have rated the stock with a hold rating and one has issued a buy rating to the company. According to MarketBeat.com, the company has a consensus rating of “Hold” and a consensus target price of $16.50.

Nu Skin Enterprises Company Profile

Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.